pcn poster

Posters

Determining Meaningful Change in Depression Symptoms Assessed With the Patient Health Questionnaire (PHQ-9) and Sheehan Disability Scale (SDS) Among Patients With Treatment Resistant Depression in Trials of Esketamine Nasal Spray

Introduction: Meaningful change thresholds (MCT) derived from clinical outcome assessments quantify the change amount during pharmacologic treatment that is meaningful to the patient. We ...

Carol Jamieson , BSc;

Stacie Hudgens , MA, MSc;

Vanina Popova , MD;

Kimberly Cooper , MS;

Wayne Drevets , MD;

Maggie Fedgchin , PharmD;

Jaskaran Singh , MD;

Lysbeth Floden , PhD;

Rosanne Lane , MD, MSc, MS;

11/22/2019

The Cost of Improving Treatment Choices: Cost and Benefit of a Digital Medicine System that Collects and Reports Objective Medication Adherence

Background: Medication adherence is critical for relapse prevention among SMI patients. In the absence of objectively collected adherence data (OCAD), managing medications is difficult. A...

Felicia Forma , BSc;

Christopher P. Young , MD, PhD;

Charles Ruetsch , PhD;

Heidi Waters , PhD, MBA;

11/22/2019

Efficacy and Safety of Dasotraline in Adults With Binge-Eating Disorder: A Randomized, Double-blind, Fixed-dose Trial

Background: In a previous flexible dose study, dasotraline, a long-acting dopamine/ norepinephrine reuptake inhibitor, demonstrated significant efficacy in the treatment of binge-eating d...

Joyce Tsai , PhD;

Justine Kent , MD;

Antony Loebel , MD;

Robert Goldman , PhD;

Brad Navia , MD, PhD;

James Hudson , MD;

Carlos Grilo , PhD;

Susan McElroy , MD;

Ling Deng , PhD;

11/22/2019

Vilazodone Efficacy Across Somatic and Psychic Symptoms of Depression: A Pooled Analysis From 4 Randomized and Placebo-Controlled Studies

Background: Vilazodone (VLZ) is a serotonin reuptake inhibitor and 5-HT1A receptor partial agonist approved for the treatment of Major Depressive Disorder (MDD). Historically, MDD studies...

Larry Culpepper , MD;

Pratap Chokka , MD, FRACP;

Ken Kramer , PhD;

11/22/2019

Assessment of Adherence and Persistence Among Patients With Major Depressive Disorder Enrolled in the tAccess Patient Support Program

Objective: To assess the impact of tAccess patient support program (PSP) on adherence and persistence among adult patients with major depressive disorder (MDD). tAccess PSP, a free progra...

Maggie McCue , MS, RD;

Janna Manjelievskaia , PhD, MPH;

Lambros Chrones , MD;

Maelys Touya , MSc, PharmD;

Debra Lawrence , PhD, MBA, MS;

11/22/2019

Evolution of a Study of Bilateral Prefrontal Transcranial Magnetic Stimulation (TMS) to Treat the Symptoms of Mild TBI (mTBI) and PTSD: Research Methods, Participant Demographics, and Tolerability

Background: TBIs have affected nearly 380,000 service members since 2000. Comorbid PTSD may result from, and exacerbate, various sequelae of mTBI. Conventional treatments for mTBI/PTSD sy...

Jared Garland , BS;

Emilia-Marie Jaskot , BS;

Jerika Taylor , MA;

Kiara Buccellato , MA;

Navneet Atwal , MD;

Paul Pasquina , MD;

11/22/2019

Evaluation of Addiction Medicine Intensive Outpatient/Partial Hospitalization Program (AMIOP/PHP) at Fort Bliss, TX

Purpose: There are currently no standardized evaluations of longitudinal outcomes for Addiction Medicine Intensive Outpatient Programs (AMIOPs) in the military. At William Beaumont Army M...

Gisela Carter , LCSW;

11/22/2019

Assessing the Quality and Conformity of Mental Status Exam Descriptors

The mental status examination (MSE) is the objective portion of the psychiatric examination. Despite this, a lack of uniformity in the MSE has contributed to variability and as a result p...

Sarah Siddiqui , DO;

Erin Baker , PhD;

Gina Penley ;

Suzanna Freerksen , MD, FAPA;

Harold Veits , MD, DFAAPA;

11/22/2019

Insulin Sensitivity and Glucose Metabolism of Olanzapine and Combination Olanzapine and Samidorphan: A Phase 1 Exploratory Study in Healthy Volunteers

Background: A combination of olanzapine and samidorphan (OLZ/SAM) is in development for schizophrenia to provide the efficacy of olanzapine while mitigating olanzapine-associated weight g...

Mark Namchuck , PhD;

John Newcomer , MD;

David McDonnell , MD;

Ying Jiang , PhD;

Christine Graham , PhD;

Linda Morrow , MD;

Carine Beysen , DPhil;

Frederico Toledo , MD;

Daiva Bajorunas , MD;

Bernard Silverman , MD;

11/22/2019

Long-term Efficacy of Lurasidone in Antipsychotic-naïve vs. Antipsychotic-exposed Adolescents With Schizophrenia: Post-hoc Analysis of a Two Year, Open-label Study

Background: Few studies have prospectively evaluated short- or long-term antipsychotic efficacy in treatment-naïve (vs. previously treated) first-episode schizophrenia. The aim of this po...

Robert Goldman , PhD;

Christoph U. Correll , MD;

Michael Tocco , PhD;

Jay Hsu , PhD;

11/22/2019

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Posters

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products